Prolific Machines uses its Photomolecular™ platform, integrating advanced Optogenetic Cell Line Development technology with AI-driven bioprocess optimization. They harness light and AI to control cellular behavior, revolutionizing biomanufacturing for pharmaceuticals, food, and other everyday essentials. Their approach aims to combat climate change, enable space-food, and improve cell therapy.
- Category
- Biomanufacturing
- Stage
- Series B
- Employees
- 62
- HQ
- Emeryville, United States
- Founded
- 2020
- Funding
- $97M